Literature DB >> 15690137

Intraventricular tanycytic ependymoma: case report and review of the literature.

Brian T Ragel1, Jeannette J Townsend, Adam S Arthur, William T Couldwell.   

Abstract

OBJECTIVE AND IMPORTANCE: Tanycytic ependymomas are a rare ependymoma subtype showing a marked predilection for the spine, with only a few reports of supratentorial tumors. We present a case of a tanycytic ependymoma arising from the lateral and third ventricle. CLINICAL
PRESENTATION: The patient was a 55-year-old woman who complained of intermittent, progressively worsening dysequilibrium for several months. The neurologic exam in the neurosurgery clinic was without deficit. INTERVENTION: MRI of the brain revealed a 3-cm, minimally enhancing lesion centered in the superior aspect of the third ventricle. The tumor involved the left wall of the third ventricle, the septum pellucidum, and the anterior horn of the left lateral ventricle. Surgery was recommended for diagnosis and to prevent obstructive hydrocephalus. A gross total resection was achievedvia a transcallosal approach. Postoperatively, the patient remained neurologically intact.
CONCLUSION: The long-term prognosis for tanycytic ependymomas is the same or slightly better than for other ependymoma subtypes. The current treatment plan includes gross total resection followed by radiologic surveillance. Repeat resection or radiation treatment will be recommended in the event of recurrence.

Entities:  

Mesh:

Year:  2005        PMID: 15690137     DOI: 10.1007/s11060-004-1371-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  13 in total

1.  The tanycytic ependymoma of the lateral ventricle: case report.

Authors:  M Daneyemez; C Can; Y Izci; A Beduk; E Timuckaynak
Journal:  Minim Invasive Neurosurg       Date:  1999-12

2.  Ganglioglioma with a tanycytic ependymoma as the glial component.

Authors:  S Hayashi; S Kameyama; M Fukuda; H Takahashi
Journal:  Acta Neuropathol       Date:  2000-03       Impact factor: 17.088

3.  Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas.

Authors:  S Suzuki; H Oka; N Kawano; S Tanaka; S Utsuki; K Fujii
Journal:  Brain Tumor Pathol       Date:  2001       Impact factor: 3.298

4.  Supratentorial ependymomas in adult patients.

Authors:  T H Schwartz; S Kim; R S Glick; E Bagiella; C Balmaceda; M R Fetell; B M Stein; M B Sisti; J N Bruce
Journal:  Neurosurgery       Date:  1999-04       Impact factor: 4.654

5.  Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.

Authors:  C Ebert; M von Haken; B Meyer-Puttlitz; O D Wiestler; G Reifenberger; T Pietsch; A von Deimling
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  Analysis of the NF2 gene in oligodendrogliomas and ependymomas.

Authors:  M Eva Alonso; M Josefa Bello; Dolores Arjona; Pilar Gonzalez-Gomez; Jesus Lomas; Jose M de Campos; M Elena Kusak; Alberto Isla; Juan A Rey
Journal:  Cancer Genet Cytogenet       Date:  2002-04-01

7.  Tanycytic ependymoma.

Authors:  L A Langford; G M Barré
Journal:  Ultrastruct Pathol       Date:  1997 Mar-Apr       Impact factor: 1.094

8.  Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

Authors:  P L Robertson; P M Zeltzer; J M Boyett; L B Rorke; J C Allen; J R Geyer; P Stanley; H Li; A L Albright; P McGuire-Cullen; J L Finlay; K R Stevens; J M Milstein; R J Packer; J Wisoff
Journal:  J Neurosurg       Date:  1998-04       Impact factor: 5.115

9.  Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.

Authors:  R A Prayson
Journal:  Am J Clin Pathol       Date:  1998-11       Impact factor: 2.493

10.  Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.

Authors:  M P Rubio; K M Correa; V Ramesh; M M MacCollin; L B Jacoby; A von Deimling; J F Gusella; D N Louis
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

View more
  8 in total

1.  The clinical features and surgical outcomes of intracranial tanycytic ependymomas: a single-institutional experience.

Authors:  Xiaogang Tao; Jinqian Dong; Zonggang Hou; Shuyu Hao; Qi Zhang; Zhen Wu; Junting Zhang; Baiyun Liu
Journal:  J Neurooncol       Date:  2017-06-26       Impact factor: 4.130

2.  Tanycytic ependymoma in a 76-year-old Puerto Rican male.

Authors:  Yvis del Mar Ortiz; Juan L Pérez Berenguer; Juan Mercado Acosta; Mario Polo; Orlando de Jesús-Garces; Irving E Vega
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Immunohistochemical study of CD99 and EMA expression in ependymomas.

Authors:  Soheir Mahfouz; Ahmad Abdel Aziz; Samia M Gabal; Samar el-Sheikh
Journal:  Medscape J Med       Date:  2008-02-19

Review 4.  Features of intraventricular tanycytic ependymoma: report of a case and review of literature.

Authors:  Shweta Agarwal; Michael E Stevenson; Michael E Sughrue; Eric P Wartchow; Gary W Mierau; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 5.  Cerebellar ependymoma with overlapping features of clear-cell and tanycytic variants mimicking hemangioblastoma: a case report and literature review.

Authors:  Xiu-Peng Zhang; Yang Liu; Di Zhang; Qin Zheng; Chen Wang; Liang Wang; Qing-Chang Li; Xue-Shan Qiu; En-Hua Wang
Journal:  Diagn Pathol       Date:  2017-03-20       Impact factor: 2.644

6.  Tanycytic ependymoma of filum terminale: Clinical characteristics and surgical outcomes.

Authors:  Zonggang Hou; Xiaogang Tao; Junting Zhang; Zhen Wu; Baiyun Liu
Journal:  Oncol Lett       Date:  2018-10-01       Impact factor: 2.967

Review 7.  Imaging of ependymomas: MRI and CT.

Authors:  E L Yuh; A J Barkovich; N Gupta
Journal:  Childs Nerv Syst       Date:  2009-04-10       Impact factor: 1.475

8.  Anaplastic supratentorial cortical ependymoma presenting as a butterfly lesion.

Authors:  David W K Ng; Nicolas K K King; Aaron S C Foo; Yih-Yian Sitoh; Hwei Yee Lee; Wai Hoe Ng
Journal:  Surg Neurol Int       Date:  2012-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.